Welcome to our dedicated page for Acacia Resh news (Ticker: ACTG), a resource for investors and traders seeking the latest updates and insights on Acacia Resh stock.
Acacia Research Corporation (Nasdaq: ACTG) is a publicly traded company that acquires and operates businesses across the industrial, energy and technology sectors, as well as managing an Intellectual Property Operations segment. The ACTG news feed on Stock Titan brings together company-issued updates and market coverage tied to these activities.
Investors following ACTG news can expect regular earnings announcements and detailed quarterly and annual financial results. Acacias releases include revenue and Adjusted EBITDA by segment for Energy Operations (Benchmark), Industrial Operations (Printronix), Manufacturing Operations (Deflecto) and Intellectual Property Operations (Acacia Research Group), along with commentary on factors such as license fee revenue, contributions from recent acquisitions and segment-level performance.
News items also cover corporate developments, including executive appointments and governance actions disclosed through Form 8-K filings and related press releases. For example, the company has reported the appointment of a Chief Financial Officer and summarized key terms of the associated employment agreement. In addition, Acacia issues updates about its participation in investor conferences and its plans to host earnings conference calls and webcasts.
Another category of ACTG news involves strategic and investment initiatives. The company has announced a Bitcoin-backed commercial loan strategy in partnership with Unchained Capital and Build Asset Management, as well as acquisitions such as Deflecto and upstream energy assets held by Benchmark. These releases provide context on how Acacia deploys its capital base and expands its operating platforms.
By monitoring the ACTG news page, readers can review historical and ongoing disclosures related to segment performance, acquisitions, financing activities, partnerships and management commentary. This centralized view helps investors and researchers see how Acacia communicates its strategy and reports on the progress of its industrial, energy, manufacturing and intellectual property operations over time.
Acacia Research Corporation (NASDAQ: ACTG) has acquired Printronix Holding Corp. for $33 million, approximately 3.6x Adjusted EBITDA from the fiscal year ended March 31, 2021. Printronix, a leader in industrial impact printers, serves diverse sectors including healthcare and logistics. Acacia's President, Clifford Press, emphasized the strategic alignment and potential for positive cash flows and growth. The acquisition aims to leverage Printronix's strong market position, enhancing Acacia's capabilities in industrial printing solutions.
Acacia Research Corporation (NASDAQ: ACTG) has sold 3.9 million shares of Oxford Nanopore Technologies in an IPO on the London Stock Exchange, raising approximately $22.3 million. Acacia retains a 4.4% stake in Oxford Nanopore, valued at $280.8 million as of October 4, reflecting a 78% uplift from its book value on June 30, 2021. The remaining shares are under a 180-day lock-up. Acacia's CEO noted the IPO's success as a testament to Oxford Nanopore's leadership in its industry.
Spok Holdings, Inc. (NASDAQ: SPOK) announced it received a proposal from Acacia Research Corporation (NASDAQ: ACTG) to acquire all outstanding shares for $10.75 per share in cash. Spok's Board plans to evaluate this offer with its financial and legal advisors. No immediate action is required from shareholders. The proposal’s future remains uncertain, as there are no assurances it will result in a formal offer or agreement. Spok continues to provide critical healthcare communication solutions, enhancing workflows in the U.S. healthcare sector.
Acacia Research Corporation (Nasdaq: ACTG) reported significant financial improvements for Q2 2021, with gross revenues rising to $17.4 million from $2.1 million year-over-year. The company achieved a GAAP net income of $18.8 million, or $0.23 per diluted share. Book value per share stood at $3.02, down from $5.94 at year-end 2020, primarily due to increased liabilities associated with warrants and preferred stock. Total capital available is $770 million, with a life sciences portfolio yielding $25.8 million in gains this quarter.
Acacia Research Corporation (NASDAQ: ACTG) will release its second quarter 2021 financial results on August 16, 2021, at 8:00 a.m. ET. A conference call will follow at 11:00 a.m. ET to discuss the results. Investors can join the call via telephone or through a live webcast on the company's website. Acacia focuses on acquiring undervalued businesses within technology, life sciences, and other sectors, aiming for value creation through its capital resources and operational expertise. The company warns that actual results may differ from forecasts due to various uncertainties.
Acacia Research Corporation (NASDAQ: ACTG) reported Q1 2021 results, showing cash and equity investments totaling $325.1 million, up from $274.6 million at year-end 2020. However, gross revenues declined to $5.8 million, with a net loss of $(136.7) million or $(2.81) per diluted share, significantly higher than the previous year’s loss of $(12.2) million. Book value fell to $2.64 per share from $5.94, primarily due to non-cash liabilities tied to derivatives. The company continues to explore acquisition opportunities in the technology and healthcare sectors.
Acacia Research Corporation (ACTG) will release its Q1 2021 financial results on May 17, 2021, at 8:00 a.m. ET. A conference call to discuss these results will follow at 11:00 a.m. ET. Investors can access the call by dialing (877) 407-0778 (U.S. and Canada) or (201) 689-8565 (international), with a simultaneous webcast on the company's website. Founded in 1993, Acacia focuses on investing in Intellectual Property Assets, partnering with inventors to maximize the financial value of patents.
Acacia Research Corporation (Nasdaq: ACTG) reported its financial results for the year ending December 31, 2020. The company completed a significant acquisition of life science assets valued at over $117.5 million, funded by $282.3 million, and recouped $188.5 million by selling some holdings. As of December 31, 2020, gross revenues reached $29.8 million, while GAAP net income surged to $88.5 million, or $1.54 per diluted share, up from a loss of $(20.4 million) the previous year. Cash reserves increased to $274.6 million, while book value climbed to $292.5 million.
Acacia Research Corporation (NASDAQ: ACTG) is set to release its fourth quarter and year-end 2020 financial results on March 29, 2021, at 8:00 a.m. ET. A conference call will follow at 11:00 a.m. ET to discuss the results. Investors can access the call at (877) 407-0778 in the U.S. and (201) 689-8565 internationally, or via webcast. Founded in 1993, Acacia specializes in investing in Intellectual Property Assets.
Acacia Research Corporation (Nasdaq: ACTG) reported Q3 2020 results, achieving $19.5 million in gross revenues and a GAAP net income of $29.2 million, or $0.32 per diluted share. This reflects a significant turnaround from a net loss of $(7.6 million) last year. Cash and short-term investments rose to $303.1 million from $184.0 million in Q2. CEO Clifford Press noted the recovery of two-thirds of their purchase price from the Woodford portfolio acquisition. A shelf registration statement on Form S-3 is expected to be filed to facilitate a rights offering for stockholders.